Patents by Inventor Humg-Yu Hsiao
Humg-Yu Hsiao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170156371Abstract: Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.Type: ApplicationFiled: February 17, 2017Publication date: June 8, 2017Inventors: David M. ANDERSON, Humg-Yu HSIAO, Lin LIU
-
Patent number: 8778648Abstract: Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.Type: GrantFiled: March 25, 2011Date of Patent: July 15, 2014Assignee: Eli Lilly and CompanyInventors: David M. Anderson, Humg-Yu Hsiao, Lin Liu
-
Publication number: 20110177195Abstract: Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.Type: ApplicationFiled: March 25, 2011Publication date: July 21, 2011Inventors: David M. Anderson, Humg-Yu Hsiao, Lin Liu
-
Publication number: 20110171344Abstract: Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.Type: ApplicationFiled: March 25, 2011Publication date: July 14, 2011Inventors: DAVID M. ANDERSON, HUMG-YU HSIAO, LIN LIU
-
Publication number: 20110171345Abstract: Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.Type: ApplicationFiled: March 25, 2011Publication date: July 14, 2011Inventors: David M. Anderson, Humg-Yu Hsiao, Lin Liu
-
Patent number: 7914782Abstract: Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.Type: GrantFiled: December 14, 2006Date of Patent: March 29, 2011Assignee: Chemgen CorporationInventors: David M. Anderson, Humg-Yu Hsiao, Lin Liu
-
Patent number: 7723091Abstract: Enzymes of a particular class, characterized by the ability to cleave a linkage that effects release of a cell-surface protein or carbohydrate, which does not contain an anti-infection agent, display significant anti-infectious activity. Upon oral administration, these enzymes are effective, for example, in the treatment of digestive tract infections in humans and in animals. In the latter, there are benefits of significantly improved growth rate, feed efficiency, and overall health.Type: GrantFiled: May 28, 2004Date of Patent: May 25, 2010Assignee: Chemgen CorporationInventors: David M. Anderson, Lin Liu, Humg-Yu Hsiao, Douglas W. Fodge
-
Publication number: 20070141041Abstract: Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.Type: ApplicationFiled: December 14, 2006Publication date: June 21, 2007Inventors: David ANDERSON, Humg-Yu Hsiao, Lin Liu
-
Publication number: 20040223961Abstract: Enzymes of a particular class, characterized by the ability to cleave a linkage that effects release of a cell-surface protein or carbohydrate, which does not contain an anti-infection agent, display significant anti-infectious activity. Upon oral administration, these enzymes are effective, for example, in the treatment of digestive tract infections in humans and in animals. In the latter, there are benefits of significantly improved growth rate, feed efficiency, and overall health.Type: ApplicationFiled: May 28, 2004Publication date: November 11, 2004Applicant: CHEMGEN CORPORATIONInventors: David M. Anderson, Lin Liu, Humg-Yu Hsiao, Douglas W. Fodge
-
Patent number: 6780628Abstract: Enzymes of a particular class, characterized by the ability to cleave a linkage that effects release of a cell-surface protein or carbohydrate, which does not contain an anti-infection agent, display significant anti-infectious activity. Upon oral administration, these enzymes are effective, for example, in the treatment of digestive tract infections in humans and in animals. In the latter, there are benefits of significantly improved growth rate, feed efficiency, and overall health.Type: GrantFiled: December 8, 2000Date of Patent: August 24, 2004Assignee: Chemgen CorporationInventors: David M. Anderson, Lin Liu, Humg-Yu Hsiao, Douglas W. Fodge
-
Publication number: 20020048576Abstract: Enzymes of a particular class, characterized by the ability to cleave a linkage that effects release of a cell-surface protein or carbohydrate, which does not contain an anti-infection agent, display significant anti-infectious activity. Upon oral administration, these enzymes are effective, for example, in the treatment of digestive tract infections in humans and in animals. In the latter, there are benefits of significantly improved growth rate, feed efficiency, and overall health.Type: ApplicationFiled: December 8, 2000Publication date: April 25, 2002Inventors: David M. Anderson, Lin Liu, Humg-Yu Hsiao, Douglas W. Fodge
-
Patent number: 6162473Abstract: A method is provided to increase the efficiency with which monogastric animals utilize low caloric content dietary rations. Addition of a hemicellulase enzyme, such as mannanase, to dietary rations that are not supplemented with concentrated fat, or which contain reduced fat content, increases the efficiency with which monogastric animals utilize the rations.Type: GrantFiled: November 3, 1998Date of Patent: December 19, 2000Assignee: Chemgen CorporationInventors: Douglas W. Fodge, Humg-Yu Hsiao
-
Patent number: 5275945Abstract: Alkaline proteases that are stable in the presence of linear alkylbenzene sulfonates can be obtained from bacteria isolated from soil and by other means. The soils are collected from an alkaline environment which has been exposed to extremely high pH and/or detergent contamination. The proteases are at least twice as stable as Esperase.TM. when stored in commercial liquid detergents.Type: GrantFiled: October 8, 1991Date of Patent: January 4, 1994Assignee: Vista Chemical CompanyInventors: Humg-Yu Hsiao, Douglas W. Fodge, James J. LaLonde
